Mangalam Drugs & Organics Limited (NSE:MANGALAM)

India flag India · Delayed Price · Currency is INR
89.22
-1.45 (-1.60%)
Jul 25, 2025, 3:29 PM IST
-1.60%
Market Cap1.41B
Revenue (ttm)3.18B
Net Income (ttm)67.21M
Shares Outn/a
EPS (ttm)4.25
PE Ratio21.00
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,424
Average Volume70,148
Open91.98
Previous Close90.67
Day's Range88.89 - 91.98
52-Week Range70.10 - 144.99
Beta-0.06
RSI58.26
Earnings DateAug 8, 2025

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, ... [Read more]

Sector Healthcare
Founded 1972
Employees 432
Stock Exchange National Stock Exchange of India
Ticker Symbol MANGALAM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.